Unknown

Dataset Information

0

Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.


ABSTRACT:

Introduction and methods

Hepatitis B is a vaccine preventable disease and is notifiable in South Africa. Hepatitis B vaccination was incorporated into the Expanded Programme on Immunisation in South Africa in 1995. We used a convenience sample from community-based febrile rash surveillance in 2013 to estimate hepatitis B sero-prevalence. Of samples serologically negative for acute measles infection, 450 samples spanning nine provinces of South Africa were tested for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs) and hepatitis B core antibody (anti-HBc).

Results

Two children (2/450; 0.4%) tested positive for HBsAg. Three hundred and three children (67.3%) had evidence of vaccine induced immunity. Vaccine induced immunity was present in 80.2% of 1-5 year olds, but only 60.3% of 10-14 year olds. Natural immunity, indicating exposure to circulating hepatitis B, was present in 13/450 (2.9%) children.

Conclusion

Chronic hepatitis B in South African has decreased in prevalence from highly endemic levels prior to vaccine introduction to approximately 0.4% in this sample, demonstrating impact of a successful vaccination programme 18 years after introduction. Decreased vaccine-induced immunity with increasing age may reflect waning antibody titres over time.

SUBMITTER: Prabdial-Sing N 

PROVIDER: S-EPMC6544234 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance.

Prabdial-Sing Nishi N   Makhathini Lillian L   Smit Sheilagh Brigitte SB   Manamela Morubula Jack MJ   Motaze Nkengafac Villyen NV   Cohen Cheryl C   Suchard Melinda Shelley MS  

PloS one 20190531 5


<h4>Introduction and methods</h4>Hepatitis B is a vaccine preventable disease and is notifiable in South Africa. Hepatitis B vaccination was incorporated into the Expanded Programme on Immunisation in South Africa in 1995. We used a convenience sample from community-based febrile rash surveillance in 2013 to estimate hepatitis B sero-prevalence. Of samples serologically negative for acute measles infection, 450 samples spanning nine provinces of South Africa were tested for hepatitis B surface a  ...[more]

Similar Datasets

| S-EPMC6821253 | biostudies-literature
| S-EPMC7733892 | biostudies-literature
2010-08-11 | GSE19442 | GEO
| S-EPMC6664530 | biostudies-literature
| PRJNA753313 | ENA
| PRJEB70907 | ENA
| S-EPMC4379032 | biostudies-literature
| S-EPMC6594001 | biostudies-literature
| S-EPMC7479371 | biostudies-literature
| S-EPMC4467221 | biostudies-literature